RecruitingPhase 4NCT05102448

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Studying Takayasu arteritis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Zhongshan Hospital
Principal Investigator
Lindi Jiang, Ph.D., M.D.
Department of Rheumatology in Zhongshan hospital, Fudan University
Intervention
Tofacitinib(drug)
Enrollment
76 enrolled
Eligibility
18-65 years · All sexes
Timeline
2021 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05102448 on ClinicalTrials.gov

Other trials for Takayasu arteritis

Additional recruiting or active studies for the same condition.

See all trials for Takayasu arteritis →

← Back to all trials